{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:30:12Z","timestamp":1790101812948,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s40272-022-00494-2","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T08:15:21Z","timestamp":1645431321000},"page":"155-161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of Mirtazapine on Nausea in Children with Functional Nausea and Functional Dyspepsia Postprandial Distress Syndrome"],"prefix":"10.1007","volume":"24","author":[{"given":"Ivonne M.","family":"Iglesias-Escabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kleesattel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee S.","family":"McDaniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Reuther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0896-079X","authenticated-orcid":false,"given":"Neha R.","family":"Santucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"494_CR1","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1053\/j.gastro.2016.02.015","volume":"150","author":"J Hyams","year":"2016","unstructured":"Hyams J, Di Lorenzo C, Saps M, et al. Childhood functional gastrointestinal disorders: child\/adolescent. Gastroenterology. 2016;150:1456\u201368.","journal-title":"Gastroenterology"},{"key":"494_CR2","unstructured":"Jilani TN, Gibbons JR, Faizy RM, et al. Mirtazapine. [Updated 2021 Aug 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519059\/. Accessed 12 Dec 2021."},{"key":"494_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.cgh.2015.09.043","volume":"14","author":"J Tack","year":"2016","unstructured":"Tack J, Giao H, Carbone F, Vanheel H, et al. Efficacy of mirtazapine in patients with functional dyspepsia and weight loss. Clin Gastroenterol Hepatol. 2016;14:385-92.e4.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"494_CR4","doi-asserted-by":"publisher","first-page":"e13146","DOI":"10.1111\/nmo.13146","volume":"29","author":"F Carbone","year":"2017","unstructured":"Carbone F, Vanuytsel T, Tack J. The effect of mirtazapine on gastric accommodation, gastric sensitivity distention, and nutrient tolerance in healthy subjects. Neurogastroenterol Motil. 2017;29(12):e13146.","journal-title":"Neurogastroenterol Motil"},{"key":"494_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/MOG.0000000000000393","volume":"33","author":"J Tack","year":"2017","unstructured":"Tack J, Carbone F. Functional dyspepsia and gastroparesis. Curr Opin Gastroenterol. 2017;33:446\u201354.","journal-title":"Curr Opin Gastroenterol"},{"key":"494_CR6","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.2147\/DDDT.S125743","volume":"11","author":"M Malamood","year":"2017","unstructured":"Malamood M, Roberts A, Kataria R, et al. Mirtazapine for symptom control in refractory gastroparesis. Drug Des Dev Ther. 2017;11:1035\u201341.","journal-title":"Drug Des Dev Ther"},{"key":"494_CR7","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2020. https:\/\/www.R-project.org\/. Accessed 7 Dec 2021."},{"key":"494_CR8","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.pnpbp.2006.03.015","volume":"30","author":"C Pae","year":"2006","unstructured":"Pae C. Low-dose mirtazapine may be successful treatment option for severe nausea and vomiting. Progress in Neuro-Psychopharmacology & Biology Psychiatry. 2006;30:1143\u20135.","journal-title":"Progress in Neuro-Psychopharmacology & Biology Psychiatry."},{"key":"494_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1517\/14728222.11.4.527","volume":"11","author":"A Thompson","year":"2007","unstructured":"Thompson A, Lummis CRS. The 5-HT3 receptor as a therapeutic target. Expert Opin Ther Targets. 2007;11:527\u201340.","journal-title":"Expert Opin Ther Targets"},{"key":"494_CR10","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.3748\/wjg.v22.i22.5260","volume":"22","author":"S Jiang","year":"2016","unstructured":"Jiang S, Jia L, Jing L, et al. Beneficial effects of antidepressant mirtazapine in functional dyspepsia patients. World J Gastroenterol. 2016;22:5260\u20136.","journal-title":"World J Gastroenterol"},{"key":"494_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5056\/jnm.2011.17.3.305","volume":"17","author":"M Coskun","year":"2011","unstructured":"Coskun M, Alyanak B. Psychiatric co-morbidity and efficacy of mirtazapine treatment in young subjects with chronic or cyclic vomiting syndromes: a case series. J Neurogastroenterol Motil. 2011;17:305\u201311.","journal-title":"J Neurogastroenterol Motil."},{"key":"494_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/0269881116681399","volume":"31","author":"J Karsten","year":"2017","unstructured":"Karsten J, Hagenauw L, Kamphuis J, et al. Low doses of mirtazapine or quetiapine for transient insomnia: a randomized, double-blind, cross-over, placebo-controlled trial. J Psychopharmacol. 2017;31:327\u201337.","journal-title":"J Psychopharmacol"},{"key":"494_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.janxdis.2007.01.005","volume":"22","author":"C Mrakotsky","year":"2008","unstructured":"Mrakotsky C, Masek B, Biederman J, et al. Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia. J Anxiety Disord. 2008;22:88\u201397.","journal-title":"J Anxiety Disord"},{"key":"494_CR14","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1089\/cap.2016.0071","volume":"26","author":"E Hosoglu","year":"2016","unstructured":"Hosoglu E, Herguner S. Childhood sleep terror and mirtazapine. J Child Adolesc Psychopharmacol. 2016;26:568.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"494_CR15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1089\/cap.2015.0145","volume":"25","author":"C Tanidir","year":"2015","unstructured":"Tanidir C, Herguner S. Mirtazapine for choking phobia: report of a pediatric case. J Child Adolesc Psychopharmacol. 2015;25:659\u201360.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"494_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.24869\/psyd.2019.421","volume":"31","author":"A Naviaux","year":"2019","unstructured":"Naviaux A. Management of Avoidant restrictive food intake disorder in a 12-year-old on a Pediatric ward in a General Hospital: Use of mirtazapine, partial hospitalization model and family-based therapy. Psychiatr Danub. 2019;31:421\u20136.","journal-title":"Psychiatr Danub"},{"key":"494_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.31887\/DCNS.2012.14.3\/cdoyle","volume":"14","author":"C Doyle","year":"2012","unstructured":"Doyle C, McDougle C. Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan. Dialogues Clin Neurosci. 2012;14:263\u201379.","journal-title":"Dialogues Clin Neurosci"},{"key":"494_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/MPG.0000000000000445","volume":"59","author":"S Hussain","year":"2014","unstructured":"Hussain S, Hyman P. Psychotropic medications for pediatric functional gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 2014;59:280\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"494_CR19","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cgh.2012.06.036","volume":"10","author":"J Tack","year":"2012","unstructured":"Tack J, Janssen P, Masaoka T, et al. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol and Hepatol. 2012;10:1239\u201345.","journal-title":"Clin Gastroenterol and Hepatol."},{"key":"494_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.coph.2018.08.015","volume":"43","author":"K Tack","year":"2018","unstructured":"Tack K, Camilleri M. New developments in the treatment of gastroparesis and functional dyspepsia. Curr Opin Pharmacol. 2018;43:111\u20137.","journal-title":"Curr Opin Pharmacol"},{"key":"494_CR21","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.297.15.1683","volume":"297","author":"J Bridge","year":"2007","unstructured":"Bridge J, Iyengar S, Salary C, et al. Clinical response and risk for reported suicidal ideation and suicidal attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007;297:1683\u201396.","journal-title":"JAMA"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-022-00494-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-022-00494-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-022-00494-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T02:18:38Z","timestamp":1648001918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-022-00494-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["494"],"URL":"https:\/\/doi.org\/10.1007\/s40272-022-00494-2","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]},"assertion":[{"value":"24 January 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"There is no financial disclosure or conflicts of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"Available upon request","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"LSU: #10116, date: 7-30-2018; CCHMC: #00002988, date: 7-30-2018","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent waivered for retrospective chart review","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent available","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Iglesias-Escabi wrote the IRB proposal, reviewed charts, collected data, interpreted the collected data, and wrote the first draft of the manuscript with input from Dr. Santucci, Dr. Hyman, and Dr. LeBlanc. Dr. McDaniel performed statistical analysis for the study.Dr. Reuther provided psychology feedback, critically review the study proposal, drafted and revised the manuscript. Dr. Kleesattel reviewed charts, collected data, performed literature search and revised the manuscript. Dr. LeBlanc assisted in graphs and tables, drafted and revised the research work. (Late) Dr. Hyman conceptualized the study, provided feedback on study design, and contributed to revision of the manuscript. Dr. Santucci conceptualized the study, provided framework for study design, supervised and mentored Dr. Iglesias to prepare the manuscript and revised each iteration of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' contributions"}}]}}